DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
ClinicalTrials.gov.
Efficacy and safety of emapalumab and anakinra in reducing hyperinflammation and respiratory distress in patients with COVID-19 infection.
US National Library of Medicine. Accessed September 28, 2020 at:
https://www.clinicaltrials.gov/ct2/show/NCT04324021
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.